How will Australia's traditional approach to health technology assessment manage a multi-million dollar one-time injection with the 'potential' to cure and add 40, 50, 60 or even 70 years of normal life expectancy? The US could lead the way. …
Do you value a lifetime benefit based on almost no evidence?
May 29, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Companies secure certification as 'Great Places to Work'
July 23, 2025 - - Latest News -
US leads the way on cell and gene therapy with new rapid access program
July 23, 2025 - - Latest News -
Neuraxpharm continues international expansion with launch of Australian affiliate
July 23, 2025 - - Latest News -
Pharmac minister asks for more in new letter of expectations
July 23, 2025 - - Latest News -
Sarepta backs down on FDA demand to halt distribution of gene therapy
July 22, 2025 - - Latest News -
Some of Pharmac's fiercest critics appointed to guide its 'reset' program
July 22, 2025 - - Latest News -
Mark Butler acknowledges dubious relationship between the PBS and US tariffs
July 22, 2025 - - Latest News